SLC32A1 and schizophrenia: A recent study by Purves-Tyson et al. found pronounced reductions in GABAergic markers, specifically vesicular GABA transporter (VGAT), parvalbumin (PV), GABRA1, GABRA2, and GABRA5 mRNAs within the ventral midbrain in schizophrenia compared to controls.